Common Contracts
3 similar Convertible Preferred Stock contracts by Ovid Therapeutics Inc., Oncothyreon Inc.
4,000 Shares Ovid Therapeutics Inc. Series A Convertible Preferred Stock UNDERWRITING AGREEMENTConvertible Preferred Stock • October 8th, 2019 • Ovid Therapeutics Inc. • Pharmaceutical preparations • New York
2,500 Shares Ovid Therapeutics Inc. Series A Convertible Preferred Stock UNDERWRITING AGREEMENTConvertible Preferred Stock • February 21st, 2019 • Ovid Therapeutics Inc. • Pharmaceutical preparations • New York
10,000 Shares ONCOTHYREON INC. Series A Convertible Preferred Stock UNDERWRITING AGREEMENTConvertible Preferred Stock • September 18th, 2014 • Oncothyreon Inc. • Services-commercial physical & biological research • New York
